6.53 -0.26 (-3.83%)

47.17% Fall from 52W High

11.9M XNAS Volume

XNAS 25 Mar, 2025 5:30 PM (EDT)

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A - RXRX - stock price prediction, stock price target, analyst ratings from 8 analysts

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A has a share price target of US$ 9, revenue growth forecast of 62.9%, and profit growth estimate of -30.6% for FY25, based on top 8 analyst calls.